Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0J9VG
|
|||
| Former ID |
DIB006582
|
|||
| Drug Name |
NSI-566
|
|||
| Synonyms |
Neural stem cell therapy (ALS, spinal cord injury, paraplegia), Neuralstem; Spinal cord stem cell therapy (ALS, spinal cord injury, paraplegia), Neuralstem; Neural stem cell therapy (ALS, spinal cord injury, paraplegia, stroke), Neuralstem
Click to Show/Hide
|
|||
| Indication | Amyotrophic lateral sclerosis [ICD-11: 8B60.0] | Phase 2 | [1] | |
| Cerebrovascular ischaemia [ICD-11: 8B1Z; ICD-10: I67.8; ICD-9: 434.91] | Phase 2 | [2] | ||
| Lateral sclerosis [ICD-11: 8B61] | Phase 2 | [2] | ||
| Spinal cord injury [ICD-11: ND51.2] | Phase 1 | [1] | ||
| Company |
Neuralstem
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025566) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.